Jonathan Skipper
Immunology
iTeos Therapeutics
Belgium
Biography
Jonathan Skipper is Executive Vice President for Technology Development at the Ludwig Institute for Cancer Research, a program that provides pre-clinical, clinical and business development support for the development of Ludwig’s research discoveries. Jonathan has over fifteen years’ experience in the management of intellectual property and technology licensing and has completed numerous partnering transactions with biopharma companies, including several Ludwig biotechnology start-ups. Jonathan received his PhD in Immunology from University College London and completed further research at the University of Virginia and the University of Oxford.
Research Interest
Immunology
